Egypt is making a strategic push to establish itself as the premier regional hub for health investment and innovation, backed by sweeping reforms and substantial public-private partnerships. During the Global Health Exhibition 2025 in Riyadh, Egypt’s Minister of Health and Population, Khaled Abdel Ghaffar, outlined the nation’s comprehensive strategy designed to attract investors and foster a resilient, tech-driven healthcare ecosystem. The minister emphasized that every dollar invested in the sector could yield up to fourfold returns in economic and social benefits, positioning Egypt’s reforms as a model for integrated health transformation.
A $3.7 Billion Overhaul of Healthcare Infrastructure
At the core of Egypt’s strategy is a massive investment of EGP 177 billion ($3.72 billion) dedicated to 1,300 health projects. This initiative aims to significantly improve the efficiency of the country’s healthcare services and increase hospital bed capacity to 1.34 beds per 1,000 citizens. The plan signals a strong government commitment to modernizing infrastructure and creating a robust foundation for private sector participation.
New Investment Models and Legal Frameworks
To attract private capital, Egypt has introduced new investment incentives and legal frameworks. Minister Abdel Ghaffar unveiled two distinct operational models: the Greenfield model, for constructing new hospitals from the ground up, and the Brownfield model, which focuses on operating and upgrading existing public facilities. These models are further supported by the new Concession Law No. 78 of 2024, which is designed to enhance transparency and provide clear guarantees and incentives for investors in the healthcare sector.
Digital Transformation in Healthcare
Egypt is rapidly advancing its digital health capabilities. The Universal Health Insurance System has already delivered over 40 million medical services valued at EGP 151 billion and issued more than 20 million digital prescriptions. This digital backbone is enabling the full digitization of hospitals and facilitating the integration of advanced technologies like AI and telemedicine, creating significant opportunities for HealthTech startups and innovators.
Localizing Pharmaceutical Manufacturing
A key pillar of Egypt’s ambition is becoming a leader in pharmaceutical and biotech manufacturing. The country has achieved remarkable success in localization, including 100% localization of Hepatitis C treatment at a cost of just $50 per patient, 79% for modern antibiotics, and 95.5% for eye solutions. Furthermore, local insulin production and the Egyptian Drug Authority’s achievement of WHO maturity level 3 underscore the nation’s growing capacity. Egypt was also selected as one of only six countries globally to receive mRNA vaccine technology, positioning it as a pivotal player in regional pharmaceutical supply chains.
About The Egyptian Ministry of Health and Population
The Egyptian Ministry of Health and Population is the government body responsible for health, well-being, and population-related affairs in Egypt. It oversees the national health system, develops and implements health policies, and works to ensure access to comprehensive and quality healthcare services for all citizens.
Source: Zawya
